References
- Aisner J, Hiponia D, Jacobs M, Belami CP. Combined modalities of head and neck cancer. Sem Oncol 1995; 22, 3, suppl 6: 28-34.
- Hainaut P. The tumor suppressor protein p53: a recep-tor to genotoxic stress that controls cell growth and survival. Curr Opin Oncol 1995; 7: 76–82.
- Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994; 266: 1821–1828.
- Kinzler KW, Vogelstein B. Clinical implications of basic research: cancer therapy meets p53. N Engl J Med 1994; 331, 1: 49–50.
- Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957–967.
- Wahl AF, Donaldson KL, Fairchild C, et al. Loss of normal p53 function confers sensitization to Taxol by increas-ing G2/M arrest and apoptosis. Nature Med 1996; 2,1: 72–79.